Company Information
Company Profile
Cerecor is a clinical-stage biopharmaceutical company developing innovative drug candidates to make a difference in the lives of patients with neurological and psychiatric disorders. Cerecor's lead drug candidate is CERC-301, which Cerecor currently intends to explore as a novel treatment for orphan neurological indications.
Contact Information
Investor Relations
ir@cerecor.com
Company Contact
Cerecor, Inc.
400 East Pratt Street
Baltimore, MD 21202